I73.1
Thromboangiitis obliterans [Buerger's disease]
Clinical Classification Guidelines
Medical Intelligence & Overview
Thromboangiitis obliterans, commonly known as Buerger's disease, is a rare condition that causes inflammation and blockage of the small and medium-sized arteries and veins in the limbs. This disease primarily affects the blood vessels of the arms and legs, leading to reduced blood flow. Over time, this can cause tissue damage and, if not managed properly, may lead to serious complications like gangrene or loss of limbs. It is most often seen in young to middle-aged men who are heavy smokers. Early diagnosis and lifestyle changes are vital for preventing progression and managing symptoms effectively.
Causes & Symptoms
Clinical Causes: Heavy cigarette smoking: The primary risk factor; most patients with Buerger's disease are smokers. Genetic predisposition: Some hereditary factors may increase susceptibility. Autoimmune components: Possible autoimmune response leading to blood vessel inflammation. Environmental factors: Rarely, exposure to certain chemicals or toxins may contribute.
Key Symptoms: Claudication: Pain in the limbs during activity, often relieved with rest. Cold sensitivity: Fingers and toes feeling abnormally cold or numb. Color changes: Pale, reddish, or bluish discoloration of the skin, especially in extremities. Ulcers and sores: Non-healing wounds on fingers or toes. Numbness or tingling: Sensory changes in affected limbs. Tissue necrosis: Advanced cases may develop tissue death, leading to gangrene. Pain at rest: In severe stages, persistent pain even without activity.
Diagnostic & Treatment
Diagnosis Path: Diagnosing Buerger's disease involves a combination of clinical evaluation and tests. A doctor may perform a physical examination to check blood flow, look for affected areas, and examine skin changes. Diagnostic tests include Doppler ultrasound to assess blood flow, angiography to visualize blood vessels, and blood tests to rule out other conditions like autoimmune diseases. A key aspect of diagnosis is identifying a history of tobacco use, especially in young patients with limb ischemia who lack traditional atherosclerosis risk factors.
Treatment Protocols: Since Buerger's disease is strongly associated with smoking, the most critical step is complete cessation of tobacco use. Additional management strategies include:
Clinical Advice & FAQs
Billing Guidance
Is I73.1 a billable ICD-10 code?
Yes, I73.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I73.1?
Clinical documentation must specify the nature of Thromboangiitis obliterans [Buerger's disease] and any associated comorbidities for accurate reporting.
Cite this Clinical Reference